-
1 Comment
Corbus Pharmaceuticals Holdings, Inc is currently in a long term downtrend where the price is trading 5.5% below its 200 day moving average.
From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 40.7.
Corbus Pharmaceuticals Holdings, Inc's total revenue sank by 74.4% to $658K since the same quarter in the previous year.
Its net income has increased by 67.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 23.4% to $-18M since the same quarter in the previous year.
Based on the above factors, Corbus Pharmaceuticals Holdings, Inc gets an overall score of 3/5.
Industry | Biotechnology |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US21833P1030 |
Sector | Healthcare |
Market Cap | 95M |
---|---|
PE Ratio | None |
Target Price | 52.1111 |
Beta | 3.2 |
Dividend Yield | None |
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CRBP using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025